ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer, due to the overexpression and/or amplification of the HER2-neu gene, accounts for around 20% of all breast cancers and has a poor prognosis compared with other breast cancer subtypes [1].